217 related articles for article (PubMed ID: 19936788)
1. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.
Xie P; Yue JB; Fu Z; Feng R; Yu JM
Ann Oncol; 2010 May; 21(5):1078-82. PubMed ID: 19914960
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
Yoon YH; Lee SH; Hong SL; Kim SJ; Roh HJ; Cho KS
Int Forum Allergy Rhinol; 2014 Oct; 4(10):845-50. PubMed ID: 25223964
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
6. [18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
Hsieh TC; Hsieh CY; Yang TY; Chen TT; Lin CY; Lin CC; Hua CH; Chiu CF; Yeh SP; Sher YP
Oncologist; 2015 May; 20(5):539-45. PubMed ID: 25876992
[TBL] [Abstract][Full Text] [Related]
7. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
8. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline
Garcia-Vicente AM; Pérez-Beteta J; Amo-Salas M; Molina D; Jimenez-Londoño GA; Soriano-Castrejón AM; Pena Pardo FJ; Martínez-González A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):73-79. PubMed ID: 29102649
[TBL] [Abstract][Full Text] [Related]
9. Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Shi Q; Yang Z; Zhang Y; Hu C
PLoS One; 2014; 9(7):e103153. PubMed ID: 25068373
[TBL] [Abstract][Full Text] [Related]
10. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
12. The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma.
Chan SC; Hsu CL; Yen TC; Ng SH; Liao CT; Wang HM
Oral Oncol; 2013 Jan; 49(1):71-8. PubMed ID: 22959277
[TBL] [Abstract][Full Text] [Related]
13. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Zhang Y; Li WF; Mao YP; Zhou GQ; Peng H; Sun Y; Liu Q; Chen L; Ma J
Oncotarget; 2016 Mar; 7(12):13612-20. PubMed ID: 26871291
[TBL] [Abstract][Full Text] [Related]
15. Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
Fei Z; Chen C; Huang Y; Qiu X; Li Y; Li L; Chen T
Medicine (Baltimore); 2019 Jul; 98(28):e16327. PubMed ID: 31305420
[TBL] [Abstract][Full Text] [Related]
16. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment [
Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
Huang Y; Feng M; He Q; Yin J; Xu P; Jiang Q; Lang J
Medicine (Baltimore); 2017 Apr; 96(17):e6721. PubMed ID: 28445287
[TBL] [Abstract][Full Text] [Related]
20. Predictive significance of pretreatment
El-Hennawy G; ElMenawi S; Nasr Said E; Zekri W; Zaghloul M; Elsalam AMA; El-Fendy H; Elantably I
Pediatr Blood Cancer; 2024 Jul; 71(7):e30998. PubMed ID: 38650170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
